Want to see CH:NWRN full AI Analyst Report?
ETFs with Newron Pharmaceuticals SpA (NWRN) Exposure
The following ETFs maintain exposure to Newron Pharmaceuticals SpA (CH:NWRN). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
12 ETFs Hold Newron Pharmaceuticals SpA (NWRN)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in NWRN |
|---|---|---|---|---|---|---|
| IBRN | iShares Neuroscience and Healthcare ETF | $6.66M | 0.47% | 0.29% | $19.04K | <0.01% |
| UFUK | UBS ETF (CH) - SPI (CHF) A-dis | $2.00B | 0.10% | 0.01% | $204.19K | 0.11% |
| SPIA | UBS ETF (CH) - SPI (R) Units -(CHF) A-acc- | $519.94M | 0.10% | 0.01% | $204.19K | 0.11% |
| XMTG | iShares Core SPI(R) ETF (CH) | $6.34B | 0.14% | <0.01% | $503.08K | 0.26% |
| SPISI | UBS ETF (CH) - SPI (R) ESG Units -(CHF) A-acc- | $2.68B | 0.12% | <0.01% | $209.51K | 0.11% |
| SPISID | UBS ETF (CH) - SPI (R) ESG Units (CHF) Adis- | $5.80M | 0.14% | <0.01% | $209.51K | 0.11% |
| AVDE | Avantis International Equity ETF | $19.65B | 0.23% | <0.01% | $457.21K | 0.19% |
| AVEU | American Century ICAV - Avantis Europe Equity Ucits Etf | $39.57M | 0.26% | <0.01% | $629.39 | <0.01% |
| AVGC | American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD | $880.70M | 0.23% | <0.01% | $4,317.39 | <0.01% |
| AVUS | Avantis Global Equity Ucits ETF | $116.86M | 0.21% | <0.01% | $4,317.39 | <0.01% |
| CADE | Avantis CIBC International Equity ETF Common Units Trust Units | $351.25M | ― | <0.01% | $1,221.53 | <0.01% |
| AVSD | Avantis Responsible International Equity ETF | $376.48M | 0.23% | <0.01% | $331.53 | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in NWRN |
|---|---|---|---|---|---|---|
| IBRN | 0.29% | iShares Neuroscience and Healthcare ETF | $6.66M | 0.47% | $19.04K | <0.01% |
| UFUK | 0.01% | UBS ETF (CH) - SPI (CHF) A-dis | $2.00B | 0.10% | $204.19K | 0.11% |
| SPIA | 0.01% | UBS ETF (CH) - SPI (R) Units -(CHF) A-acc- | $519.94M | 0.10% | $204.19K | 0.11% |
| XMTG | <0.01% | iShares Core SPI(R) ETF (CH) | $6.34B | 0.14% | $503.08K | 0.26% |
| SPISI | <0.01% | UBS ETF (CH) - SPI (R) ESG Units -(CHF) A-acc- | $2.68B | 0.12% | $209.51K | 0.11% |
| SPISID | <0.01% | UBS ETF (CH) - SPI (R) ESG Units (CHF) Adis- | $5.80M | 0.14% | $209.51K | 0.11% |
| AVDE | <0.01% | Avantis International Equity ETF | $19.65B | 0.23% | $457.21K | 0.19% |
| AVEU | <0.01% | American Century ICAV - Avantis Europe Equity Ucits Etf | $39.57M | 0.26% | $629.39 | <0.01% |
| AVGC | <0.01% | American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD | $880.70M | 0.23% | $4,317.39 | <0.01% |
| AVUS | <0.01% | Avantis Global Equity Ucits ETF | $116.86M | 0.21% | $4,317.39 | <0.01% |
| CADE | <0.01% | Avantis CIBC International Equity ETF Common Units Trust Units | $351.25M | ― | $1,221.53 | <0.01% |
| AVSD | <0.01% | Avantis Responsible International Equity ETF | $376.48M | 0.23% | $331.53 | <0.01% |
Popular ETF Comparisons
NWRN ETF Exposure FAQ
What ETFs hold Newron Pharmaceuticals SpA stock?
Newron Pharmaceuticals SpA (CH:NWRN) is currently held by 12 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to CH:NWRN include iShares (DE:XMTG), Avantis (AVDE) and UBS (CH:SPISI).
Which ETF has the largest exposure to CH:NWRN?
The ETF with the largest exposure to CH:NWRN is iShares (DE:XMTG), with approximately CHF 503.08K in market value exposure.
How much CH:NWRN stock is held by ETFs?
ETFs currently hold approximately CHF 1.82M worth of Newron Pharmaceuticals SpA (CH:NWRN) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.